In conclusion, genomic analyses of a Japanese population vaccinated with different hepatitis vaccines (Heptavax-II and Bimmugen) revealed that there are specific HLA-DRB1-DQB1 haplotypes with different responses, although the genetic factors involved in vaccine responsiveness are very similar. The gene discussed is HLA-DRB1; the disease is hepatitis A virus infection.